ACTIVE

AMNASSEN

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

989,5 k €

+68.1% YoY

Gross margin

1 M €

+101.5% YoY

Equity

10,2 M €

+10.8% YoY

What does AMNASSEN do?

AMNASSEN is a Private limited company incorporated in 2005. Its main activity is: Management consultancy activities. Its registered office is in Woluwe-Saint-Pierre.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0877.651.545

Incorporation

01/12/2005

Legal form

Private limited company

Registered office

Avenue des Cormorans 15
1150 Woluwe-Saint-Pierre · BruxellesSee on map

Contributed capital

18 600,00 €

Latest accounts

31/12/2025

Activities (NACE)

70200Management consultancy activities· main 70210Public relations and communication activities 70220Business and other management consultancy activities 73300Advertising and market research 74141Specialised design activities 46190Agents involved in the sale of a variety of goods+8

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	1 M €	+101%	504,7 k €	-0.1%	505,4 k €	+6.0%	476,7 k €	+1302%	34 k €	+135%	-96,9 k €	-118%	540,7 k €	+58.9%	340,4 k €	+55.8%	218,5 k €	-25.6%	293,8 k €	-16.9%	353,4 k €	+6.9%	330,7 k €	+187%	115,3 k €	+25.6%	91,8 k €	+48.7%	61,8 k €	+546%	9,6 k €	+341%	-4 k €	-157%	6,9 k €	-15.8%	8,2 k €	+1594%	-550,5 €
EBITDA	954,5 k €	+109%	455,7 k €	+21.5%	375,1 k €	+21.0%	310 k €	+379%	-111 k €	+54.1%	-241,9 k €	-151%	475,5 k €	+43.0%	332,5 k €	+53.2%	217 k €	-25.5%	291,4 k €	-16.8%	350,2 k €	+6.7%	328,2 k €	+192%	112,3 k €	+24.5%	90,2 k €	+51.1%	59,7 k €	+851%	6,3 k €	+243%	-4,4 k €	-168%	6,5 k €	-20.0%	8,1 k €	+1159%	-765,4 €
Operating result	914,4 k €	+102%	452,1 k €	+21.9%	371 k €	+67.2%	221,9 k €	+178%	-284 k €	-5.5%	-269,2 k €	-161%	442,1 k €	+57.7%	280,4 k €	+52.3%	184,1 k €	-30.5%	264,8 k €	-24.0%	348,2 k €	-5.8%	369,8 k €	+452%	67 k €	-23.9%	88,1 k €	+70.0%	51,8 k €	+19629%	-265,2 €	+94.8%	-5,1 k €	-185%	6 k €	-2.6%	6,2 k €	+910%	-765,4 €
Net result	989,5 k €	+68.1%	588,6 k €	+340%	133,8 k €	+273%	35,9 k €	-99.6%	8,4 M €	+6182%	-137,6 k €	-333%	59,2 k €	-59.3%	145,4 k €	+44.5%	100,6 k €	-64.0%	279,7 k €	-35.7%	435 k €	+318%	104 k €	+184%	36,6 k €	-32.0%	53,9 k €	+79.3%	30,1 k €	+1305%	-2,5 k €	+57.3%	-5,8 k €	-283%	3,2 k €	-32.0%	4,7 k €	+724%	-750,2 €
Balance sheet
Equity	10,2 M €	+10.8%	9,2 M €	+0.7%	9,1 M €	+0.2%	9,1 M €	-0.7%	9,2 M €	-10.6%	10,2 M €	+547%	1,6 M €	+53.7%	1 M €	+3.0%	999,2 k €	-18.8%	1,2 M €	+52.7%	805,3 k €	+101%	400,3 k €	+12.3%	356,4 k €	+11.5%	319,7 k €	+20.3%	265,8 k €	+2321%	11 k €	-18.5%	13,5 k €	+1.2%	13,3 k €	+31.4%	10,1 k €	+85.9%	5,4 k €
Total assets	16,1 M €	+9.2%	14,7 M €	-0.1%	14,7 M €	+21.9%	12,1 M €	+7.1%	11,3 M €	-1.7%	11,5 M €	+342%	2,6 M €	+60.1%	1,6 M €	-13.3%	1,9 M €	+3.2%	1,8 M €	+13.9%	1,6 M €	+75.8%	906,2 k €	+11.2%	814,7 k €	-0.6%	819,9 k €	+41.1%	581 k €	+364%	125,2 k €	+331%	29,1 k €	+18.9%	24,4 k €	-1.3%	24,7 k €	+327%	5,8 k €
Cash	1,6 M €	+199%	538,1 k €	-45.4%	984,8 k €	+35.8%	725,3 k €	-53.1%	1,5 M €	+386%	318,5 k €	-38.5%	517,8 k €	+106%	250,8 k €	-42.9%	439,4 k €	+20.8%	363,8 k €	+55.4%	234,1 k €	+440%	43,4 k €	-66.3%	128,9 k €	+202%	42,7 k €	-72.6%	156,1 k €	+121%	70,7 k €	+1072%	6 k €	+99.5%	3 k €	-75.9%	12,5 k €	+130%	5,4 k €
Debts	5,8 M €	+5.6%	5,5 M €	-2.3%	5,6 M €	+87.5%	3 M €	+40.2%	2,1 M €	+183%	756,1 k €	-25.6%	1 M €	+71.0%	594,4 k €	-32.0%	874 k €	+49.5%	584,8 k €	-25.8%	787,9 k €	+55.7%	505,9 k €	+10.4%	458,4 k €	-8.1%	498,6 k €	+58.2%	315,1 k €	+176%	114,2 k €	+633%	15,6 k €	+40.2%	11,1 k €	-24.0%	14,6 k €	+4131%	345,4 €

Estimate

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

François BLONDEL

Director

Active

Ended mandates

François BLONDEL

Managing director

Ended

François BLONDEL

Manager

Ended

PACTORBIS

Manager · 0842.169.539

Represented by Thomas Blondel

Ended

Thomas BLONDEL

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
ASKLEPIOS Capital● Active	1017.076.078
INNODE● Active	0465.880.805
Invest 4 Biosourcing● Active	0739.833.252
Invest 4 Cardiatis● Active	0739.833.549
Invest 4 OnoDNA● Active	0739.835.925

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	11/08/2026	25/06/2025	19/06/2024	31/08/2023	01/08/2022	26/07/2021
General meeting	01/06/2026	02/06/2025	03/06/2024	05/06/2023	07/06/2022	07/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

22 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	01/06/2026	11/08/2026	French	PDF
Micro model	31/12/2024	02/06/2025	25/06/2025	French	PDF
Micro model	31/12/2023	03/06/2024	19/06/2024	French	PDF
Micro model	31/12/2022	05/06/2023	31/08/2023	French	PDF
Micro model	31/12/2021	07/06/2022	01/08/2022	French	PDF
Micro model	31/12/2020	07/06/2021	26/07/2021	French	PDF
Micro model	31/12/2019	02/06/2020	09/07/2020	French	PDF
Micro model	31/12/2018	03/06/2019	09/08/2019	French	PDF
Micro model	31/12/2017	04/06/2018	24/07/2018	French	PDF
Micro modelCorrection	31/12/2016	06/06/2017	07/06/2018	French	PDF
Micro model	31/12/2016	06/06/2017	21/06/2017	French	PDF
Abridged modelCorrection	31/12/2015	06/06/2016	07/06/2018	French	PDF
Abridged model	31/12/2015	06/06/2016	23/06/2016	French	PDF
Abridged model	31/12/2014	01/06/2015	27/07/2015	French	PDF
Abridged model	31/12/2013	02/06/2014	23/06/2014	French	PDF
Abridged model	31/12/2012	03/06/2013	06/08/2013	French	PDF
Abridged model	31/12/2011	04/06/2012	25/06/2012	French	PDF
Abridged model	31/12/2010	06/06/2011	12/07/2011	French	PDF
Abridged model	31/12/2009	07/06/2010	23/08/2010	French	PDF
Abridged model	31/12/2008	01/06/2009	11/09/2009	French	PDF
Abridged model	31/12/2007	02/06/2008	17/10/2008	French	PDF
Abridged model	31/12/2006	04/06/2007	27/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

François BLONDEL

Director

Active

Ended mandates

François BLONDEL

Managing director

Ended

François BLONDEL

Manager

Ended

PACTORBIS

Manager · 0842.169.539

Represented by Thomas Blondel

Ended

Thomas BLONDEL

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates08/12/2023
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
PDF
Mandates09/07/2019
DEMISSIONS, NOMINATIONS
PDF
Capital / shares15/01/2018
CAPITAL, ACTIONS
PDF
Mandates23/08/2016
DEMISSIONS, NOMINATIONS
PDF
Mandates25/10/2012
DEMISSIONS, NOMINATIONS
PDF
Mandates16/01/2012
DEMISSIONS, NOMINATIONS
PDF
Mandates13/09/2011
DEMISSIONS, NOMINATIONS
PDF
Capital / shares20/07/2011
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025989,5 k €↑
2024
Annual accounts 2024588,6 k €↑
2023
Annual accounts 2023133,8 k €↑
2022
Annual accounts 202235,9 k €↓
2021
Annual accounts 20218,4 M €↑
2020
Annual accounts 2020-137,6 k €↓
2019
Annual accounts 201959,2 k €↓
2018
Annual accounts 2018145,4 k €↑
2017
Annual accounts 2017100,6 k €↓
2016
Annual accounts 2016279,7 k €↓
2015
Annual accounts 2015435 k €↑
2014
Annual accounts 2014104 k €↑
2013
Annual accounts 201336,6 k €↓
2012
Annual accounts 201253,9 k €↑
2011
Annual accounts 201130,1 k €↑
2010
Annual accounts 2010-2,5 k €↑
2009
Annual accounts 2009-5,8 k €↓
2008
Annual accounts 20083,2 k €↓
2007
Annual accounts 20074,7 k €↑
2006
Annual accounts 2006-750,2 €
01/12/2005
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

AMNASSEN

Overview

What does AMNASSEN do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline